Matt Wiley
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matt Wiley
BioXcel Therapeutics, Inc. reported in an 8-K filed September 19, 2024 that Matt Wiley was terminated as Chief Commercial Officer, effective October 2, 2024. Matt Wiley has spoken on 2 earnings calls across 1 company, most recently for BioXcel Therapeutics, Inc. on November 10, 2022.
“On September 18, 2024, the Company notified Matt Wiley, the Company’s Chief Commercial Officer, that, in connection with the Clinical Prioritization, his position was being eliminated. The Company and Mr. Wiley agreed that he would cease his employment in this role effective October 2, 2024 and would serve as a consultant for a period of time thereafter.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
BioXcel Therapeutics, Inc. (BTAIQ)
Source not stated
Start not stated–2024-10-02
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.